Reset filters
  • 26 July 2007

IAS: Roche admits long-standing low-level contamination of nelfinavir

Read the article
  • 24 July 2007

IAS: Vicriviroc still effective at 48 weeks in treatment-experienced, but relationship with cancer remains uncertain

Read the article
  • 23 July 2007

IAS: Skin cancers more common among HIV-positive people, screening recommended

Read the article
  • 23 July 2007

IAS: HPV therapeutic vaccine stimulates immune response in people with HIV

Read the article
  • 6 July 2007

Cancer: further evidence that long-term immune suppression will boost risk for people with HIV

Read the article
  • 21 June 2007

Roche agrees to temporary suspension of nelfinavir's (Viracept) European license - updated

Read the article
  • 20 June 2007

Near-global nelfinavir (Viracept) recall 'very difficult situation'

Read the article
  • 29 May 2007

HIV contributes to lung cancer risk, independent of smoking

Read the article
  • 11 May 2007

HPV vaccine shows good efficacy, but how valuable will it be in 'real world' settings?

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.